Live Quote · NASDAQIMCRHealthcare· Biotechnology

Immunocore Holdings plc

$34.96▲ 1.42%(+$0.49)
TickerSpark Score
66/100
▌ Solid
40
Valuation
40
Profitability
95
Growth
76
Health
80
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMCR research report →

52-Week Range56% of range
Low
$27.55
Current
$34.96
High
$40.72
Company Overviewwww.immunocore.com

About the company

Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for patients with uveal melanoma that is either unresectable or has metastasized.

CEO
Bahija Jallal
IPO
2021
Employees
524
HQ
Abingdon, OX, GB

Price Chart

-3.45% · this period
$40.22$34.00$27.79Jul 17Jan 15Jul 17

Get TickerSpark's AI analysis on IMCR

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in